FindTrial
Sign In

Exploratory research of proteomics using human tear fluid samples

Exploratory research of proteomics using human tear fluid samples - Exploratory research of proteomics using human tear fluid samples

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000055692
Enrollment
Unknown
Registered
2024-10-02
Start date
2024-06-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye

Interventions

None listed

Sponsors

Santen Pharmaceutical Co. Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects who received an investigational drug including placebo at the study sites and consented to the collection and use of tear fluid samples

Exclusion criteria

Exclusion criteria: Subjects who were unable to collect tear fluid samples at either baseline or post treatment

Design outcomes

Primary

MeasureTime frame
Protein expression profile data—

Countries

Japan

Contacts

Public ContactYuki Togashi

Santen Pharmaceutical Co. Ltd. Ophthalmology Innovation center

translational.research@santen.com06-4802-9339

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026